Health-related quality of life (HRQoL) outcomes with darolutamide in the phase 3 ARANOTE trial.

Authors: Alicia K. Morgans, Kunhi Parambath Haresh, Mindaugas Jievaltas, David Olmos, Neal D. Shore, Egils Vjaters, Nianzeng Xing, Ateesha F. Mohamed, Natasha Littleton, Shankar Srinivasan, Frank Verholen, Fred Saad

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.5004

Source: Full article

---

Abstract

5004